A study of World Trade Center responders has found that post-traumatic stress disorder (PTSD) is associated with molecular changes linked to accelerated biological aging and an increased risk of chronic diseases. The findings, published in Nature Communications, could provide new insights into the long-term physical health consequences of PTSD.
The research, led by Stony Brook University, analyzed blood samples from 393 World Trade Center responders approximately 18 years after the September 11, 2001 attacks. Of those sampled, 232 had been diagnosed with PTSD, while 161 had not.
Researchers identified significant differences in 114 proteins and seven metabolites between the two groups. These alterations were associated with brain function, immune activity, energy metabolism, cellular protection, and cell communication and repair processes. The study also indicated signs of accelerated biological aging in multiple organs, including the heart, kidneys, liver, and lungs, among responders with PTSD.
These biological changes may help explain the higher incidence of chronic conditions such as heart disease, lung disease, cognitive decline, and other age-related illnesses observed in individuals with long-term PTSD. Lead study author Benjamin Luft described PTSD as a "whole-body illness" rather than solely a mental health disorder, noting that traumatic experiences can lead to lasting biological changes that persist for decades.
"These changes appear to accelerate aspects of biological aging and may increase the risk of many chronic diseases," Luft stated. He also highlighted alterations in proteins critical for healthy brain function, including those involved in cell communication, damage repair, and maintaining memory and cognitive processes.
The study was partially funded by the CDC, the National Institute for Occupational Safety, and the National Institutes of Health. Luft expressed "cautious optimism," emphasizing that the research strengthens the understanding of PTSD as a condition with significant long-term physical health implications.
Dr. Marc Siegel, a medical analyst not involved in the study, commented that the results are "fascinating," suggesting PTSD is tied to both emotional and physical trauma, leading to immune dysregulation and aging processes. He noted that chronic diseases following the 9/11 attacks were intertwined with impacts on physical and emotional well-being, longevity, and multiple organ systems.
Study limitations were acknowledged by the researchers. Because measurements were taken at a single point in time, the study can only show an association, not a direct causal link between PTSD and the observed biological changes. Further studies are underway to examine changes over time. Additionally, the findings may not be universally applicable to all individuals with PTSD, as the study focused on a unique population with specific trauma and environmental exposures. The representation of women in the study was also limited, comprising only 10% of responders. Researchers also noted that blood tests provide an indirect reflection of brain processes.
Moving forward, additional research is needed to determine if these blood markers can predict disease progression or treatment response. Luft underscored the public health importance of recognizing PTSD as a chronic medical condition. He advocated for investment in early diagnosis, comprehensive treatment, and long-term follow-up for trauma survivors, including first responders and veterans, to improve quality of life and reduce the burden of chronic disease.